11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Role of Toll-like receptors in systemic Candida albicans infections.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Toll-like receptors (TLRs) constitute a family of pattern-recognition receptors (PRRs) that recognize molecular signatures of microbial pathogens and function as sensors for infection. Recognition of Candida albicans by TLRs on mature immune cells, such as phagocytic cells, activates intracellular signalling pathways that trigger production of proinflammatory cytokines which are critical for innate host defence and orchestrate the adaptive response. TLR2, and TLR4 in a minor extent, recognize cell wall-associated ligands; endosomal TLR9 and TLR7 recognize DNA and RNA respectively. Interaction of C. albicans with TLRs is a complex process, as TLRs may collaborate with other PRRs and expression of surface-associated fungal ligands depends on the strain and the morphotype (yeasts or hyphae), thus defining the final induced adaptive response (Th1/Th2/Th17). TLRs are also expressed on hematopoietic stem and progenitor cells (HSPCs) where they may play a role in modulating hematopoiesis; engagement of TLR2 induces, upon recognition of C. albicans, the differentiation of HSPCs towards specific subsets of mature myeloid cells. This has opened a new perspective for anti-Candida immunointervention.

          Related collections

          Author and article information

          Journal
          Front Biosci (Landmark Ed)
          Frontiers in bioscience (Landmark edition)
          1093-4715
          1093-4715
          Jan 01 2016
          : 21
          Affiliations
          [1 ] Departament de Microbiologia i Ecologia, Universitat de Valencia, Burjassot, Spain.
          [2 ] Board of Governors Regenerative Medicine Institute and Research Division of Immunology, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
          [3 ] Departament de Microbiologia i Ecologia, Universitat de Valencia, Burjassot, Spain, daniel.gozalbo@uv.es.
          Article
          4388
          10.2741/4388
          26709773
          ef3db4a0-1ad7-4541-9ab5-f28423354909
          History

          Comments

          Comment on this article